Cargando…
Activation of cGAS-STING Signal to Inhibit the Proliferation of Bladder Cancer: The Immune Effect of Cisplatin
Cisplatin is commonly used in neoadjuvant, adjuvant, and systemic therapy for advanced bladder cancer, but its immune-related mechanism is still unclear. Exploration of the immune effects of cisplatin in bladder cancer would complement the comprehensive mechanism of cisplatin and provide the basis f...
Autores principales: | Fu, Guanghou, Wu, Yunfei, Zhao, Guanan, Chen, Xiaoyi, Xu, Zhijie, Sun, Junjie, Tian, Junjie, Cheng, Zhengjun, Shi, Yue, Jin, Baiye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564335/ https://www.ncbi.nlm.nih.gov/pubmed/36230972 http://dx.doi.org/10.3390/cells11193011 |
Ejemplares similares
-
POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma
por: Tian, Junjie, et al.
Publicado: (2023) -
Population-based outcome of muscle-invasive bladder cancer following radical cystectomy: who can benefit from adjuvant chemotherapy?
por: Tian, Junjie, et al.
Publicado: (2021) -
SAA1 Has Potential as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, and an Indicator for Immune Infiltration of Tumor Microenvironment in Clear Cell Renal Cell Carcinoma
por: Xu, Zhijie, et al.
Publicado: (2023) -
RCC1 functions as a tumor facilitator in clear cell renal cell carcinoma by dysregulating cell cycle, apoptosis, and EZH2 stability
por: Wu, Yunfei, et al.
Publicado: (2023) -
Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma
por: Wu, Yunfei, et al.
Publicado: (2023)